⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31088403 | 1.00 | — | — | |
| SCHEMBL31312465 | 0.86 | — | — | |
| SCHEMBL93041 | 0.81 | — | — | |
| SCHEMBL31589213 | 0.79 | — | — | |
| SCHEMBL643177 | 0.77 | TAAR1 (0.63) | — | |
| Ethylene SCHEMBL27825961 | 0.77 | TAAR1 (0.52) | — | |
| SCHEMBL31588815 | 0.77 | — | — | |
| SCHEMBL4399626 | 0.75 | TAAR1 (0.74) | — | |
| SCHEMBL9200966 | 0.75 | TAAR1 (0.60) | — | |
| SCHEMBL81535 | 0.74 | TAAR1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179055-A1 | Substituted 2-(pyrrolidine-3-yl)acetic acid derivative, preparation method and use thereof | INNOVSTONE THERAPEUTICS LIMITED (CN) | 2025-06-05 | — | — | US | disclosed |
| WO-2025103442-A1 | SUBSTITUTED 2-(PYRROLIDIN-3-YL)ACETIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翊石医药科技有限公司 | 2025-05-22 | — | — | WO | disclosed |
| WO-2024263563-A1 | METABOTROPIC GLUTAMATE SUBTYPE-2 AND -3 RECEPTOR POSITIVE ALLOSTERIC MODULATORS AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2024-12-26 | — | — | WO | disclosed |
| WO-2024199457-A1 | COMPOUND HAVING RING FUSED STRUCTURE, PREPARATION METHOD THEREFOR AND USE THEREOF, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 苏州安赛隆医药科技有限公司 | 2024-10-03 | — | — | WO | disclosed |
| CN-118724903-A | Compound with fused ring structure, its preparation method and use, and pharmaceutical composition and use | 苏州安赛隆医药科技有限公司 | 2024-10-01 | — | — | CN | disclosed |